What is AMGN's current stock price?

As of now, AMGN is trading at $292.20, with a daily change of -0.39%.

What are the risks associated with AMGN stock?

AMGN Key risk is its Low Risk Level, .

What is AMGN next earnings date?

AMGN next earnings report is scheduled for Nov 4, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AMGN Stock Analysis & IQ Rating | Amgen

AMGN

Amgen

$292.20

-$0.69 | -0.39%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 335.88

MKT CAP

$ 157.07B

52W Low

$ 253.3

VOL

$ 908.28K

P/E Ratio

23.87

AVG VOL

$ 2.49M

RSI

50.05

TREND

Uptrend

AMGN Stock IQ

Login to see Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AMGN Target Price

Login to display

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Upgraded on attractively valued

AMGN Rewards

Trading below its fair value

Chart

$273.97 (+6.65%)

$296.81 (-1.55%)

$287.01 (+1.81%)

$321.91 (-9.23%)

1year

6month

3month

1month

AMGN Risk Level

AMGN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

AMGN Analysts Opinion

AMGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is negative and it remained unchanged from the past 3 months

AMGN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

25%

92%

AMGN Street Opinion

AMGN Street view is extremely bullish and have positive views on the near-term outlook

AMGN Performance Sentiment

Sentiments overview associated with AMGN events and the stock performance.

79%

17%

Positive

Negative

19 out of 24
events present

4 out of 24
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$294.50

Resistance
Price

$271.18

Current Price Range

$303.33

Show methods +

AMGN Earnings

The TTM reflects 12-month period, providing review of AMGN financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

34,917

33,424

28,190

+11.29%

Cost of Revenue

12,401

12,858

8,451

+21.14%

Gross Profit

22,516

20,566

19,739

+6.80%

Operating Exp

14,324

13,308

11,842

+9.98%

Operating Inc

8,192

7,258

7,897

+1.85%

Net Interest Inc

-2,940

-3,155

-2,875

-

Interest Exp

2,940

3,155

2,875

+1.12%

Other Inc Exp

2,172

506

2,833

-12.44%

EPS Growth

12.32

7.62

12.56

-0.96%

AMGN Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.2

Next Earnings Date: Nov 4, 2025

Linked to AMGN

IQ

Close Price

Change

MRNA

3.87

26.74

+1.87%

BIIB

3.95

149.91

-0.13%

EXEL

3.94

38.72

+1.88%

CRSP

4.08

67.61

+0.58%

CHRS

3.50

1.65

-1.20%

AMGN Latest Analysis +

1 Top Dividend Growth Stock to Buy Right Now. Key PointsAmgen faced some patent cliffs this year but its financial results remain strong.

Fri Oct 24, 2025

$292.20 | -0.39%

Potential

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know. Amgen (AMGN) closed at $292.89 in the latest trading session marking a -1.04% move from the prior day.

Thu Oct 23, 2025

$292.89 | -1.04%

Momentum

Notable Monday Option Activity: AMGN ISRG EXEL. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 12526 contracts has been traded thus far today a contract volume which is representative of approximately 1.3

Mon Oct 20, 2025

$303.33 | +1.51%

Momentum

Oppenheimer Highlights Amgens (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study. Amgen Inc. (NASDAQ:AMGN) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Amgen Inc. (NASDAQ:AMGN) is a California-based biopharmaceutical company. On October 3 Op⁠penheimer reaffirm‍ed its‌ O‌utpe‍rform ratin‌g on Amgen Inc. (NASDAQ:AMGN) with a price target of $380. The‌ firm high‌lighted Amgens solid performance and al‌so repor⁠ted tha‌t‌ its VESALIUS-CV trial reached

Thu Oct 16, 2025

$295.81 | -0.51%

Potential

Amgen (AMGN) Laps the Stock Market: Heres Why. In the closing of the recent trading day Amgen (AMGN) stood at $297.32 denoting a 1.18% move from the preceding trading day.

Wed Oct 15, 2025

$297.32 | +1.18%

Momentum

Whirlpool Expands United States Manufacturing Presence with $300 Million Investment in Ohio Operations. CLYDE Ohio Oct. 15 2025 (GLOBE NEWSWIRE) -- Ohio Gov. Mike DeWine Whirlpool Corp. JobsOhio Regional Growth Partnership (RGP) and One Columbus today announced that Whirlpool will invest $300 million across its manufacturing facilities in Clyde and Marion Ohio — a move expected to create at least 448 and up to 600 new jobs and further solidify Ohio'.s position as a national leader in advance

Wed Oct 15, 2025

$297.32 | +1.18%

Activity

Amgen (AMGN) Announces Launch of AmgenNow.

Tue Oct 14, 2025

$293.85 | +0.49%

Activity

Why Amgen (AMGN) Could Beat Earnings Estimates Again. Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Mon Oct 13, 2025

$292.40 | +0.78%

Earnings

Potential

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention. Amgen Inc. (NASDAQ:AMGN) is one of the best growth stocks to buy now. On October 2 Amgen announced that its landmark Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints confirming that Repatha (evolocumab) significantly reduced the risk of Major Adverse Cardiovascular Events/MACE in high-risk individuals without a prior history of heart attack or [….]

Mon Oct 13, 2025

$292.40 | +0.78%

Potential

Amgen Unveils New DTC Program Cuts Cholesterol Drug Price by 60%. AMGN rolls out AmgenNow a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.

Tue Oct 7, 2025

$295.54 | +0.15%

Activity

FAQ About AMGN Stock Insights

What is AMGN current stock price?

What are AMGN stock strengths?

What risks are associated with AMGN stock?

When is AMGN next earnings report?

What is AMGN market cap and volume?

What is AMGN's current Stock IQ?

Should I buy AMGN stock right now?

Is AMGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AMGN?

What does a 'Strong Sell' rating mean for AMGN?

What factors influence AMGN's Stock IQ?

Explore our AMGN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AMGN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AMGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AMGN

Amgen

Current Price

$292.20

-$0.69 | -0.39%

52W High

$ 335.88

MKT CAP

$ 157.07B

52W Low

$ 253.3

VOL

$ 908.28K

P/E Ratio

23.87

AVG VOL

$ 2.49M

RSI

50.05

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AMGN Rewards

Earnings are forecast to grow

AMGN Rewards

Upgraded on attractively valued

AMGN Rewards

Trading below its fair value

Linked to AMGN

Symbol

IQ

Close

Change

MRNA

3.87

26.74

+1.87%

BIIB

3.95

149.91

-0.13%

EXEL

3.94

38.72

+1.88%

CRSP

4.08

67.61

+0.58%

CHRS

3.50

1.65

-1.20%

AMGN Stock IQ

Login to unlock Amgen (AMGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$273.97 (+6.65%)

$296.81 (-1.55%)

$287.01 (+1.81%)

$321.91 (-9.23%)

1year

6month

3month

1month

AMGN Analysts Opinion

AMGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AMGN Analysts Opinion

AMGN Analysts opinion is negative and it remained unchanged from the past 3 months

AMGN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

25%

92%

AMGN Street Opinion

AMGN Street view is extremely bullish and have positive views on the near-term outlook

AMGN Risk Level

AMGN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

AMGN Performance Sentiment

Sentiments overview associated with AMGN events and the stock performance.

79%

17%

Positive

Negative

19 out of 24
events present

4 out of 24
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$294.50

Resistance
Price

$271.18

Current Price Range

$303.33

Show methods +

AMGN Earnings

The TTM data reflects the most recent 12-month period, providing overview of AMGN financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

34,917

33,424

28,190

+11.29%

Cost of Revenue

12,401

12,858

8,451

+21.14%

Gross Profit

22,516

20,566

19,739

+6.80%

Operating Exp

14,324

13,308

11,842

+9.98%

Operating Inc

8,192

7,258

7,897

+1.85%

Net Interest Inc

-2,940

-3,155

-2,875

-

Interest Exp

2,940

3,155

2,875

+1.12%

Other Inc Exp

2,172

506

2,833

-12.44%

EPS Growth

12.32

7.62

12.56

-0.96%

AMGN Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

3.2

Next Earnings Date: Nov 4, 2025

AMGN Latest Analysis

1 Top Dividend Growth Stock to Buy Right Now. Key PointsAmgen faced some patent cliffs this year but its financial results remain strong.

Fri Oct 24, 2025

$292.20 | -0.39%

Potential

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know. Amgen (AMGN) closed at $292.89 in the latest trading session marking a -1.04% move from the prior day.

Thu Oct 23, 2025

$292.89 | -1.04%

Momentum

Notable Monday Option Activity: AMGN ISRG EXEL. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 12526 contracts has been traded thus far today a contract volume which is representative of approximately 1.3

Mon Oct 20, 2025

$303.33 | +1.51%

Momentum

Oppenheimer Highlights Amgens (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study. Amgen Inc. (NASDAQ:AMGN) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Amgen Inc. (NASDAQ:AMGN) is a California-based biopharmaceutical company. On October 3 Op⁠penheimer reaffirm‍ed its‌ O‌utpe‍rform ratin‌g on Amgen Inc. (NASDAQ:AMGN) with a price target of $380. The‌ firm high‌lighted Amgens solid performance and al‌so repor⁠ted tha‌t‌ its VESALIUS-CV trial reached

Thu Oct 16, 2025

$295.81 | -0.51%

Potential

Amgen (AMGN) Laps the Stock Market: Heres Why. In the closing of the recent trading day Amgen (AMGN) stood at $297.32 denoting a 1.18% move from the preceding trading day.

Wed Oct 15, 2025

$297.32 | +1.18%

Momentum

Whirlpool Expands United States Manufacturing Presence with $300 Million Investment in Ohio Operations. CLYDE Ohio Oct. 15 2025 (GLOBE NEWSWIRE) -- Ohio Gov. Mike DeWine Whirlpool Corp. JobsOhio Regional Growth Partnership (RGP) and One Columbus today announced that Whirlpool will invest $300 million across its manufacturing facilities in Clyde and Marion Ohio — a move expected to create at least 448 and up to 600 new jobs and further solidify Ohio'.s position as a national leader in advance

Wed Oct 15, 2025

$297.32 | +1.18%

Activity

Amgen (AMGN) Announces Launch of AmgenNow.

Tue Oct 14, 2025

$293.85 | +0.49%

Activity

Why Amgen (AMGN) Could Beat Earnings Estimates Again. Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Mon Oct 13, 2025

$292.40 | +0.78%

Earnings

Potential

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention. Amgen Inc. (NASDAQ:AMGN) is one of the best growth stocks to buy now. On October 2 Amgen announced that its landmark Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints confirming that Repatha (evolocumab) significantly reduced the risk of Major Adverse Cardiovascular Events/MACE in high-risk individuals without a prior history of heart attack or [….]

Mon Oct 13, 2025

$292.40 | +0.78%

Potential

Amgen Unveils New DTC Program Cuts Cholesterol Drug Price by 60%. AMGN rolls out AmgenNow a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.

Tue Oct 7, 2025

$295.54 | +0.15%

Activity

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AMGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AMGN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AMGN Stock Analysis & IQ Rating | Amgen

AMGN Stock IQ

AMGN Target Price

AMGN Risk Level

AMGN Analysts Opinion

AMGN Street Consensus

AMGN Performance Sentiment

Technical Price Levels

AMGN Financial Health

Explore our AMGN Stock insights

Receive our AMGN Daily Alerts

AMGN Stock IQ

AMGN Street Consensus

AMGN Risk Level

Technical Price Levels

Discover AMGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

Receive our AMGN Daily Alerts

AMGN Runner Alarm